News

Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

Read more

New tool for visualizing molecule properties developed at the Max Perutz Labs

Nucleic acids and proteins can be described on different structural levels, but all depend on the most basic - the primary structure. It describes the…

Read more

“I am excited by the idea that we discover the unknown about the most fundamental things in life.”

Originally from Turkey, Elif Karagöz’s scientific journey brought her to Germany to do her Master’s and to the Netherlands for her PhD at Utrecht…

Read more

Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th

Live webcast beginning at 8:30am EDT / 2:30pm CEST

 

Read more

Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate

Based on DSMB clearance, two lead dosage levels have been selected for ongoing Phase 2 clinical development

Read more

HOOKIPA Pharma Announces Oral Presentation of HB-101 CMV Vaccine Phase 1 Data at the American Transplant Congress

HOOKIPA Pharma Inc. announced that it has secured an oral presentation of Phase 1 data from its HB-101 cytomegalovirus (CMV) clinical program…

Read more

Vienna BioCenter hosts first EMBO Fellow Mini-Symposium

On June 4th and 5th, EMBO fellows got together at the Vienna BioCenter for a range of exciting talks and discussions.

Read more

First Max Perutz Day kicks off a new era at the Max Perutz Labs Vienna

On the occasion of Max Perutz’ 105th birthday, the science community, students and stakeholders from the University of Vienna and the Medical…

Read more

EMBO workshop at the Vienna BioCenter in September to discuss genome organisation by SMC complexes

The European Molecular Biology Organization (EMBO) will hold the workshop “Organization of bacterial and eukaryotic genomes by SMC complexes” at the…

Read more

New video tutorial on how to use SLAMseq for profiling transcriptional responses to drugs

In a new video format, IMP scientist Matthias Muhar explains step by step how SLAMseq can be used to profile cells’ transcriptional responses to…

Read more

Phages take center stage in a new animation by biolution

New visualization of the T4phage attacking E.coli bacteria

Read more

An amplified spindle

The Gerlich lab at IMBA - Institute of Molecular Biotechnology shows how molecular self-organization shapes the cell division machinery.

Read more